Pinto A, Fidalgo P, Cravo M, Midões J, Chaves P, Rosa J, dos Anjos Brito M, Leitão C N
Serviço de Gastrenterologia, Lisboa, Portugal.
Dis Colon Rectum. 1999 Jun;42(6):788-95; discussion 795-6. doi: 10.1007/BF02236937.
Short chain fatty acids are the main energy source of colonocytes and their use may be impaired in chronic radiation proctitis. The aim of the present study was to evaluate the therapeutic effect of short chain fatty acid enemas in patients with chronic radiation proctitis.
A prospective, randomized, double-blind trial comparing short chain fatty acid enemas with placebo was conducted in 19 patients with chronic radiation proctitis. Short chain fatty acid enemas contained 60 mM sodium acetate, 30 mM sodium propionate, and 40 mM sodium butyrate. The treatment period lasted five weeks and patients were followed up for six months.
On admission, both groups were similar regarding all parameters evaluated. After five weeks short chain fatty acid-treated patients showed a significant decrease in the number of days with rectal bleeding from the previous week (4.4+/-1.8 to 1.4+/-2.2; P = 0.001) and an improvement of endoscopic score (4.8+/-1.4 to 2.2+/-1.2; P = 0.001). Hemoglobin values were also significantly higher in short chain fatty acid-treated patients (13.1+/-0.9 g/dl vs. 10.7+/-2.1 g/dl; P = 0.02). Mucosal DNA and protein concentrations decreased in both groups but significantly so only in placebo-treated patients (P = 0.05). Changes in histologic parameters were not significant in either group. Although short chain fatty acid-treated patients did not get worse in the next six months, placebo-treated ones gradually improved, and at the end of six months, differences between the two groups were no longer observed.
Short chain fatty acid enemas can accelerate the process of healing in chronic radiation proctitis, but treatment has to be continuous if a complete and sustained clinical, endoscopic, and histologic response is to be obtained.
短链脂肪酸是结肠细胞的主要能量来源,在慢性放射性直肠炎中其利用可能受损。本研究的目的是评估短链脂肪酸灌肠剂对慢性放射性直肠炎患者的治疗效果。
对19例慢性放射性直肠炎患者进行了一项前瞻性、随机、双盲试验,比较短链脂肪酸灌肠剂与安慰剂。短链脂肪酸灌肠剂含有60 mM醋酸钠、30 mM丙酸钠和40 mM丁酸钠。治疗期持续5周,患者随访6个月。
入院时,两组在所有评估参数方面相似。5周后,接受短链脂肪酸治疗的患者前一周直肠出血天数显著减少(从4.4±1.8降至1.4±2.2;P = 0.001),内镜评分有所改善(从4.8±1.4降至2.2±1.2;P = 0.001)。接受短链脂肪酸治疗的患者血红蛋白值也显著更高(13.1±0.9 g/dl对10.7±2.1 g/dl;P = 0.02)。两组黏膜DNA和蛋白质浓度均下降,但仅安慰剂治疗组下降显著(P = 0.05)。两组组织学参数变化均不显著。尽管接受短链脂肪酸治疗的患者在接下来的6个月中没有恶化,但安慰剂治疗的患者逐渐改善,在6个月末,两组之间不再观察到差异。
短链脂肪酸灌肠剂可加速慢性放射性直肠炎的愈合过程,但如果要获得完整且持续的临床、内镜和组织学反应,治疗必须持续进行。